Strategies on drug development targeting on aging and Alzheimer with Prof. Evandro Fei Fang

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/21/3b/be/213bbe66-7a8c-3a5d-7011-96f9be64b323/mza_1747005262675932524.jpg/600x600bb.jpg

VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA

VitaDAO

35 episodes

6 hours ago

Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs. 👉vitadao.com

Technology

RSS

All content for VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA is the property of VitaDAO and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Technology

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/15308511/15308511-1638803549740-47bc81d2de916.jpg

Strategies on drug development targeting on aging and Alzheimer with Prof. Evandro Fei Fang

VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA

29 minutes 45 seconds

2 years ago

Strategies on drug development targeting on aging and Alzheimer with Prof. Evandro Fei Fang

Evandro F. Fang is a molecular gerontologist, leading an international anti-aging laboratory at the University of Oslo; his team is composed of 15+ trainees from 7+ countries. He did his PhD with Chair Professor Tzi Bun Ng at the Chinese University of Hong Kong on anti-cancer drug development (Jan. 2009-Dec.)